S Gardam… - Expert Opinion on Therapeutic …, 2011 - informahealthcare.com ... The kinase NIK as a therapeutic target in multiplemyeloma. Posted online on January 5, 2011. ... Next section. Introduction: Multiplemyeloma (MM) is a neoplasm derived from B lymphocytes and often results in uncontrolled clonal expansion of antibody-secreting cells. ... Related articles - All 5 versions
TR Spitzer, M Sykes, N Tolkoff-Rubin… - …, 2011 - journals.lww.com ... Long-Term Follow-Up of Recipients of Combined Human Leukocyte Antigen-Matched Bone Marrow and Kidney Transplantation for MultipleMyeloma With End-Stage Renal Disease. ... Renal failure is a common complication of multiplemyeloma. ... Cited by 4 - Related articles - All 5 versions
MA Chapman, MS Lawrence, JJ Keats, K Cibulskis… - Nature, 2011 - nature.com ... Initial genome sequencing and analysis of multiplemyeloma. ... larger number of cases would permit the identification of biologically relevant patterns that would not otherwise be evident. Landscape of multiplemyeloma mutations. ... Cited by 19 - Related articles - All 6 versions
[HTML] from smw.chP Samaras, M Blickenstorfer, SR Haile… - Swiss medical …, 2011 - smw.ch ... 2011;141:w13203. Validation of prognostic factors and survival of patients with multiplemyeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience. ... MM multiplemyeloma. MR minor remission. nCR near complete remission. ... Related articles - Cached - All 3 versions